Future Biosimilars: Upcoming Patent Expirations and Market Entry
Biosimilars are set to transform healthcare as major biologics lose patent protection between 2025 and 2030. Learn which drugs are next, how they differ from generics, and why adoption is slow despite massive cost-saving potential.
